Matches in SemOpenAlex for { <https://semopenalex.org/work/W2409653301> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2409653301 endingPage "7" @default.
- W2409653301 startingPage "404" @default.
- W2409653301 abstract "To determine the chemosensitivity in fresh biopsy specimen of human oral and maxillofacial cancer, and the differential chemosensitivity among those drugs used popularly in clinic.Human biopsy cancer cells were obtained from 150 oral and maxillofacial malignant tumors. The antitumor drugs tested using modified MTT assay were cisplatin (CDDP), 5-fluorouracil (5-Fu), Pinyangmycin (PYM), Paclitaxel (Taxol), Teniposide (Vm-26), Epi-adriamycin (E-ADM), Vindesin (VDS) and Methortrexatum (MTX).The success rate of the MTT assay was 93.33% (140 of the 150 cases). At a drug concentration of Cmax x 5, the inhibition rates of oral tumor cells were 63.76% for Vm-26, 25.93% for CDDP, 25.86% for E-ADM, 23.52% for Taxol, 22.97% for PYM, 22.08% for 5-Fu, 18.42% for VDS and 18.93% for MTX. The inhibition rate of VM26 was significantly higher than any of other seven chemotherapeutic drugs (P < 0.05). Over forty percent patients with squamous cell carcinoma showed moderate chemosensitivity to VM-26, CDDP and E-ADM, and over forty percent cases with adenoid carcinoma showed moderate chemosensitivity to Vm-26, Taxol and E-ADM.Most oral and maxillofacial cancers showed chemosensitivity to Vm-26, CDDP, E-ADM and Taxol. Vm-26, E-ADM and Taxol were more potent drugs than VDS, 5-Fu and MTX against oral and maxillofacial cancer cells. Chemosensitivity testing using modified MTT assay was useful in selecting antitumor drugs for patients with oral and maxillofacial cancers." @default.
- W2409653301 created "2016-06-24" @default.
- W2409653301 creator A5005111121 @default.
- W2409653301 creator A5017201728 @default.
- W2409653301 creator A5020988675 @default.
- W2409653301 creator A5048123391 @default.
- W2409653301 creator A5072187489 @default.
- W2409653301 date "2002-11-01" @default.
- W2409653301 modified "2023-09-25" @default.
- W2409653301 title "[Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens]." @default.
- W2409653301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12641948" @default.
- W2409653301 hasPublicationYear "2002" @default.
- W2409653301 type Work @default.
- W2409653301 sameAs 2409653301 @default.
- W2409653301 citedByCount "4" @default.
- W2409653301 crossrefType "journal-article" @default.
- W2409653301 hasAuthorship W2409653301A5005111121 @default.
- W2409653301 hasAuthorship W2409653301A5017201728 @default.
- W2409653301 hasAuthorship W2409653301A5020988675 @default.
- W2409653301 hasAuthorship W2409653301A5048123391 @default.
- W2409653301 hasAuthorship W2409653301A5072187489 @default.
- W2409653301 hasConcept C121608353 @default.
- W2409653301 hasConcept C126322002 @default.
- W2409653301 hasConcept C142724271 @default.
- W2409653301 hasConcept C143998085 @default.
- W2409653301 hasConcept C1491633281 @default.
- W2409653301 hasConcept C185592680 @default.
- W2409653301 hasConcept C2775934546 @default.
- W2409653301 hasConcept C2776694085 @default.
- W2409653301 hasConcept C2777292972 @default.
- W2409653301 hasConcept C2778076430 @default.
- W2409653301 hasConcept C2778119113 @default.
- W2409653301 hasConcept C2778239845 @default.
- W2409653301 hasConcept C2778707968 @default.
- W2409653301 hasConcept C2780783641 @default.
- W2409653301 hasConcept C55493867 @default.
- W2409653301 hasConcept C71924100 @default.
- W2409653301 hasConcept C98274493 @default.
- W2409653301 hasConceptScore W2409653301C121608353 @default.
- W2409653301 hasConceptScore W2409653301C126322002 @default.
- W2409653301 hasConceptScore W2409653301C142724271 @default.
- W2409653301 hasConceptScore W2409653301C143998085 @default.
- W2409653301 hasConceptScore W2409653301C1491633281 @default.
- W2409653301 hasConceptScore W2409653301C185592680 @default.
- W2409653301 hasConceptScore W2409653301C2775934546 @default.
- W2409653301 hasConceptScore W2409653301C2776694085 @default.
- W2409653301 hasConceptScore W2409653301C2777292972 @default.
- W2409653301 hasConceptScore W2409653301C2778076430 @default.
- W2409653301 hasConceptScore W2409653301C2778119113 @default.
- W2409653301 hasConceptScore W2409653301C2778239845 @default.
- W2409653301 hasConceptScore W2409653301C2778707968 @default.
- W2409653301 hasConceptScore W2409653301C2780783641 @default.
- W2409653301 hasConceptScore W2409653301C55493867 @default.
- W2409653301 hasConceptScore W2409653301C71924100 @default.
- W2409653301 hasConceptScore W2409653301C98274493 @default.
- W2409653301 hasIssue "6" @default.
- W2409653301 hasLocation W24096533011 @default.
- W2409653301 hasOpenAccess W2409653301 @default.
- W2409653301 hasPrimaryLocation W24096533011 @default.
- W2409653301 hasRelatedWork W1974028357 @default.
- W2409653301 hasRelatedWork W1976065299 @default.
- W2409653301 hasRelatedWork W2053778437 @default.
- W2409653301 hasRelatedWork W2358157763 @default.
- W2409653301 hasRelatedWork W2373869694 @default.
- W2409653301 hasRelatedWork W2392315366 @default.
- W2409653301 hasRelatedWork W2409653301 @default.
- W2409653301 hasRelatedWork W4234420077 @default.
- W2409653301 hasRelatedWork W2182019145 @default.
- W2409653301 hasRelatedWork W2485572103 @default.
- W2409653301 hasVolume "37" @default.
- W2409653301 isParatext "false" @default.
- W2409653301 isRetracted "false" @default.
- W2409653301 magId "2409653301" @default.
- W2409653301 workType "article" @default.